Literature DB >> 25867401

Polymorphisms of uric transporter proteins in the pathogenesis of gout in a Chinese Han population.

W Wan1, X Xu1, D B Zhao2, Y F Pang1, Y X Wang1.   

Abstract

In this study, we analyzed single nucleotide polymorphisms (SNP) in urate transporter genes to examine the pathogenesis of gout. We conducted a 1:1-matched case-control study that included 110 patients with acute gout attacks as the patient group and 110 healthy age- and gender-matched subjects as the control group. Clinical parameters were recorded and blood biochemistry tests were conducted for both groups. Multivariate logistic regression analysis was used to analyze the data. Hyperuricemia, hypercholesterolemia, and hypertriglyceridemia were found to be the main risk factors for the onset of gout, with relative risks of 29.2 (P < 0.001), 25.5 (P = 0.003), and 11.2 (P < 0.001). For all detected SNP, rs2231142, located in ABCG2, showed the largest frequency differences for the G/G, G/T, and T/T genotypes between groups: the distribution of these genotypes in the case group was 22, 49, and 26 individuals, respectively, and was 54, 38, and 9 individuals, respectively, in the control group. There was a statistically significant difference between the 2 groups (P < 0.001) and the odds ratio was 7.091 (95% confidence interval = 2.867-17.541). Other SNPs (rs1165196, rs1165205, rs1183201, rs17300741, rs2078267, rs2242206, rs3733591, and rs9358856) showed no significant difference between the groups (P > 0.05). The risk factors of gout were hyperuricemia, hypercholesterolemia, hypertriglyceridemia, and the T/T genotype of the rs2231142 locus in the ABCG2 gene; expression of the G/G genotype may be a protective factor against gout development.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25867401     DOI: 10.4238/2015.March.30.13

Source DB:  PubMed          Journal:  Genet Mol Res        ISSN: 1676-5680


  6 in total

1.  A functional SNP in the 3'-UTR of TAP2 gene interacts with microRNA hsa-miR-1270 to suppress the gene expression.

Authors:  Bridgett Knox; Yong Wang; Lora J Rogers; Jiekun Xuan; Dianke Yu; Huaijin Guan; Jiwei Chen; Tieliu Shi; Baitang Ning; Susan A Kadlubar
Journal:  Environ Mol Mutagen       Date:  2017-12-05       Impact factor: 3.216

Review 2.  Association between SLC2A9 (GLUT9) gene polymorphisms and gout susceptibility: an updated meta-analysis.

Authors:  Xu Zhang; Xiao Yang; Mengmeng Wang; Xiaona Li; Qing Xia; Shengqian Xu; Jianhua Xu; Guoqi Cai; Li Wang; Lihong Xin; Yanfeng Zou; Faming Pan
Journal:  Rheumatol Int       Date:  2016-06-02       Impact factor: 2.631

3.  Polymorphisms in GCKR, SLC17A1 and SLC22A12 were associated with phenotype gout in Han Chinese males: a case-control study.

Authors:  Zhao-Wei Zhou; Ling-Ling Cui; Lin Han; Can Wang; Zhi-Jian Song; Jia-Wei Shen; Zhi-Qiang Li; Jian-Hua Chen; Zu-Jia Wen; Xiao-Min Wang; Yong-Yong Shi; Chang-Gui Li
Journal:  BMC Med Genet       Date:  2015-08-20       Impact factor: 2.103

Review 4.  ABCG2 polymorphisms in gout: insights into disease susceptibility and treatment approaches.

Authors:  M C Cleophas; L A Joosten; L K Stamp; N Dalbeth; O M Woodward; Tony R Merriman
Journal:  Pharmgenomics Pers Med       Date:  2017-04-20

Review 5.  Multiple Membrane Transporters and Some Immune Regulatory Genes are Major Genetic Factors to Gout.

Authors:  Weifeng Zhu; Yan Deng; Xiaodong Zhou
Journal:  Open Rheumatol J       Date:  2018-07-24

6.  The association between genetic polymorphisms in ABCG2 and SLC2A9 and urate: an updated systematic review and meta-analysis.

Authors:  Thitiya Lukkunaprasit; Sasivimol Rattanasiri; Saowalak Turongkaravee; Naravut Suvannang; Atiporn Ingsathit; John Attia; Ammarin Thakkinstian
Journal:  BMC Med Genet       Date:  2020-10-21       Impact factor: 2.103

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.